Inogen (NASDAQ: INGN) reported Q3 EPS of $0.73, $0.21 better than the analyst estimate of $0.52. Revenue for the quarter came in at $95.3 million versus the consensus estimate of $90.94 million.

GUIDANCE:

Inogen sees FY2018 revenue of $345-355 million, versus the consensus of $349.97 million. Further, the Company is narrowing its full year 2018 GAAP net income and non-GAAP net income guidance range to $46 to $48 million, from $45 to $48 million, representing growth of 119.0% to 128.5% compared to 2017 GAAP net income of $21.0 million and growth of 61.0% to 67.9% compared to 2017 non-GAAP net income of $28.6 million. Inogen is reducing its guidance range for full year 2018 Adjusted EBITDA to $60 to $62 million, down from $65 to $69 million, representing growth of 18.0% to 22.0% versus 2017 full year results due to continued sales and marketing investments expected in the fourth quarter of 2018.

Inogen sees FY2019 revenue of $430-440 million, versus the consensus of $429.5 million. The Company forecasts full year 2019 GAAP net income to be in the range of $48 to $52 million, representing growth of 2.1% to 10.6% over the 2018 guidance mid-point of $47 million. The Company is also providing a guidance range for full year 2019 Adjusted EBITDA of $67 to $71 million, representing 9.8% to 16.4% growth over the 2018 guidance mid-point of $61 million.

For earnings history and earnings-related data on Inogen (INGN) click here.